Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids

被引:17
作者
Aziz, Hossameldin A. [1 ]
Moustafa, Gamal A. I. [1 ,5 ]
Abuo-Rahma, Gamal El-Din A. [1 ,2 ]
Rabea, Safwat M. [1 ]
Hauk, Glenn [3 ]
Krishna, Vagolu S. [4 ]
Sriram, Dharmarajan [4 ]
Berger, James M. [3 ]
Abbas, Samar H. [1 ]
机构
[1] Minia Univ, Fac Pharm, Dept Med Chem, Al Minya 61519, Egypt
[2] Deraya Univ, Dept Pharmaceut Chem, New Minia, Minia, Egypt
[3] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD USA
[4] Birla Inst Technol & Sci Pilani, Dept Pharm, Hyderabad Campus, Hyderabad, India
[5] Univ Southampton, Dept Chem, Southampton, Hants, England
关键词
antibacterial; antitubercular; cleavable DNA complex; fluoroquinolones; nitric oxide; DNA GYRASE; DERIVATIVES; ANTIMYCOBACTERIAL; BINDING; DESIGN;
D O I
10.1002/ardp.202000180
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of nitric oxide-donating fluoroquinolone/oximes was prepared in this study. The nitric oxide release from the prepared compounds was measured using a modified Griess colorimetric method. The antitubercular evaluation of the synthesized compounds indicated that ketone derivatives2band2eand oximes3band3dexhibited somewhat higher activity than their respective parent fluoroquinolones. Mycobacterial DNA cleavage studies and molecular modeling ofMycobacterium tuberculosisDNA gyrase were pursued to explain the observed bioactivity. More important, antibacterial evaluation showed that oximes3c-eare highly potent againstKlebsiella pneumoniae, with minimum inhibitory concentration (MIC) values of 0.06, 0.08, and 0.034 mu M, respectively, whereas ketone2cand oxime4care more active againstStaphylococcus aureusthan ciprofloxacin (MIC values: 0.7, 0.38, and 1.6 mu M, respectively). Notably, the antipseudomonal activities of compounds2aand4cwere much higher than those of their respective parent fluoroquinolones.
引用
收藏
页数:14
相关论文
共 30 条
[1]   New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells [J].
Ahmed, Fatma F. ;
Abd El-Hafeez, Amer Ali ;
Abbas, Samar H. ;
Abdelhamid, Dalia ;
Abdel-Aziz, Mohamed .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 :705-722
[2]   Mechanism of Quinolone Action and Resistance [J].
Aldred, Katie J. ;
Kerns, Robert J. ;
Osheroff, Neil .
BIOCHEMISTRY, 2014, 53 (10) :1565-1574
[3]   Mycobacterium tuberculosis DNA gyrase:: Interaction with quinolones and correlation with antimycobacterial drug activity [J].
Aubry, A ;
Pan, XS ;
Fisher, LM ;
Jarlier, V ;
Cambau, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1281-1288
[4]  
Aziz HA., 2020, EUR J CHEM, V8, P119, DOI [10.5155/eurjchem.8.2.119-124.1549, DOI 10.5155/EURJCHEM.8.2.119-124.1549]
[5]   New fluoroquinolones/nitric oxide donor hybrids: design, synthesis and antitubercular activity [J].
Aziz, Hossameldin A. ;
Moustafa, Gamal A. I. ;
Abbas, Samar H. ;
Hauk, Glenn ;
Krishna, Vagolu Siva ;
Sriram, Dharmarajan ;
Berger, James M. ;
Abuo-Rahma, Gamal El-Din A. .
MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (08) :1272-1283
[6]   Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis [J].
Blower, Tim R. ;
Williamson, Benjamin H. ;
Kerns, Robert J. ;
Berger, James M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (07) :1706-1713
[7]   Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method [J].
Bonev, Boyan ;
Hooper, James ;
Parisot, Judicael .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) :1295-1301
[8]   Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survival [J].
Ciccone, R ;
Mariani, F ;
Cavone, A ;
Persichini, T ;
Venturini, G ;
Ongini, E ;
Colizzi, V ;
Colasanti, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2299-2302
[9]   World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions [J].
Di Angelantonio, Emanuele ;
Kaptoge, Stephen ;
Pennells, Lisa ;
De Bacquer, Dirk ;
Cooney, Marie Therese ;
Kavousi, Maryam ;
Stevens, Gretchen ;
Riley, Leanne ;
Savin, Stefan ;
Altay, Servet ;
Amouyel, Philippe ;
Assmann, Gerd ;
Bell, Steven ;
Ben-Shlomo, Yoav ;
Berkman, Lisa ;
Beulens, Joline W. ;
Bjorkelund, Cecilia ;
Blaha, Michael J. ;
Blazer, Dan G. ;
Bolton, Thomas ;
Bonita, Ruth ;
Brenner, Beaglehole Hermann ;
Brunner, Eric J. ;
Casiglia, Edoardo ;
Chamnan, Parinya ;
Choi, Yeun-Hyang ;
Chowdhury, Rajiv ;
Coady, Sean ;
Crespo, Carlos J. ;
Cushman, Mary ;
Dagenais, Gilles R. ;
D'Agostino, Ralph B. ;
Daimon, Makoto ;
Davidson, Karina W. ;
Engstrom, Gunnar ;
Fang, Xianghua ;
Ford, Ian ;
Gallacher, John ;
Gansevoort, Ron T. ;
Gaziano, Thomas Andrew ;
Giampaoli, Simona ;
Grandits, Greg ;
Grimsgaard, Sameline ;
Grobbee, Diederick E. ;
Gudnason, Vilmundur ;
Guo, Qi ;
Humphries, Steve ;
Iso, Hiroyasu ;
Jukema, J. Wouter ;
Kauhanen, Jussi .
LANCET GLOBAL HEALTH, 2019, 7 (10) :E1332-E1345
[10]   Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis [J].
dos Santos Fernandes, Guilherme Felipe ;
de Souza, Paula Carolina ;
Marino, Leonardo Biancolino ;
Chegaev, Konstantin ;
Guglielmo, Stefano ;
Lazzarato, Loretta ;
Fruttero, Roberta ;
Chung, Man Chin ;
Pavan, Fernando Rogerio ;
dos Santos, Jean Leandro .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 :523-531